Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Connect Biopharmaceuticals
Biotech
Connect reduces China workforce, mulls strategy for asthma drug
In a year that has seen Connect walk away from a Pfizer collab and halt preclinical work, the biotech is now “significantly reducing” its China presence
James Waldron
Sep 6, 2024 4:37am
J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders
Jun 14, 2024 8:30am
Connect uncouples from Pfizer by scrapping eczema pact
Apr 17, 2024 6:38am
Connect blames 'challenging environment' for lead program pause
Jan 3, 2023 7:55am
Chasing BMS and Pfizer, Connect fails ulcerative colitis trial
May 4, 2022 7:53am
Connect Biopharma touts positive data for Dupixent rival
Nov 22, 2021 5:30am